KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Current Deferred Revenue: 2017-2025

Historic Current Deferred Revenue for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $56.4 million.

  • Guardant Health's Current Deferred Revenue rose 73.54% to $56.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.4 million, marking a year-over-year increase of 73.54%. This contributed to the annual value of $41.6 million for FY2024, which is 81.66% up from last year.
  • Per Guardant Health's latest filing, its Current Deferred Revenue stood at $56.4 million for Q3 2025, which was down 7.08% from $60.7 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Current Deferred Revenue ranged from a high of $60.7 million in Q2 2025 and a low of $7.3 million during Q3 2021.
  • Moreover, its 3-year median value for Current Deferred Revenue was $32.5 million (2024), whereas its average is $34.4 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first fell by 29.62% in 2021, then skyrocketed by 134.44% in 2024.
  • Over the past 5 years, Guardant Health's Current Deferred Revenue (Quarterly) stood at $11.3 million in 2021, then soared by 87.18% to $21.2 million in 2022, then increased by 8.02% to $22.9 million in 2023, then skyrocketed by 81.66% to $41.6 million in 2024, then surged by 73.54% to $56.4 million in 2025.
  • Its Current Deferred Revenue stands at $56.4 million for Q3 2025, versus $60.7 million for Q2 2025 and $44.0 million for Q1 2025.